ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,182,000 | -54.2% | 45,000 | -70.7% | 2.50% | -50.2% |
| Q3 2021 | $9,135,000 | -2.2% | 153,400 | +12.0% | 5.03% | -14.0% |
| Q2 2021 | $9,343,000 | +27.2% | 137,000 | +29.5% | 5.84% | -2.8% |
| Q1 2021 | $7,343,000 | -34.4% | 105,828 | -27.4% | 6.01% | +16.3% |
| Q4 2020 | $11,194,000 | -8.2% | 145,700 | -10.6% | 5.17% | -10.8% |
| Q3 2020 | $12,195,000 | -14.7% | 163,057 | -28.2% | 5.80% | -5.5% |
| Q2 2020 | $14,303,000 | -18.8% | 227,212 | -45.9% | 6.14% | -25.5% |
| Q1 2020 | $17,623,000 | +18.2% | 419,602 | +27.9% | 8.24% | +25.9% |
| Q4 2019 | $14,904,000 | +99.6% | 328,129 | +101.1% | 6.54% | +58.0% |
| Q3 2019 | $7,467,000 | -22.5% | 163,133 | -0.7% | 4.14% | -14.7% |
| Q2 2019 | $9,633,000 | -14.9% | 164,300 | -34.9% | 4.86% | -1.9% |
| Q1 2019 | $11,320,000 | +4.7% | 252,500 | -9.1% | 4.95% | -11.3% |
| Q4 2018 | $10,814,000 | -3.7% | 277,650 | +13.8% | 5.58% | -10.8% |
| Q3 2018 | $11,231,000 | +84.6% | 244,050 | +74.9% | 6.26% | +40.4% |
| Q2 2018 | $6,083,000 | +27.9% | 139,528 | +15.9% | 4.46% | +49.5% |
| Q1 2018 | $4,756,000 | – | 120,400 | – | 2.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |